Evidence map›Paper›PMID 34572393›Full record

ArticleBiomedicines2021

Plasma Concentrations of Lysophosphatidic Acid and Autotaxin in Abstinent Patients with Alcohol Use Disorder and Comorbid Liver Disease.

María Flores-López, Nuria García-Marchena, Francisco Javier Pavon, Estrella Lara, Oscar Porras-Perales, Pedro Araos, Nerea Requena-Ocaña, Sandra Torres-Galván, M Carmen Mañas-Padilla, Gabriel Rubio and 6 more

Open access · goldAbstract read
In one paragraph

Article in Biomedicines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

María Flores-LópezInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.
Nuria García-MarchenaInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.
Francisco Javier PavonInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.ORCID 0000-0002-5256-8904
Estrella LaraDepartamento de Fisiología Humana, Histología Humana, Anatomía Patológica Y Educación Física y Deportiva, Facultad de Medicina, Universidad de Málaga, 29071 Málaga, Spain.ORCID 0000-0001-7990-064X
Oscar Porras-PeralesInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.
Pedro AraosInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.ORCID 0000-0001-5172-8796
Nerea Requena-OcañaInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.
Sandra Torres-GalvánInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.
M Carmen Mañas-PadillaDepartamento de Psicobiología y Metodología de las Ciencias del Comportamiento, Facultad de Psicología, Universidad de Málaga, 29071 Málaga, Spain.
Gabriel RubioServicio de Psiquiatría, Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.
Juan SuárezInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.ORCID 0000-0001-5254-9802
Luis J SantínInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.ORCID 0000-0003-0894-8536
Fernando Rodríguez de FonsecaInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.ORCID 0000-0002-4516-5795
Estela Castilla-OrtegaInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.ORCID 0000-0002-4496-1167
María I García-FernándezDepartamento de Fisiología Humana, Histología Humana, Anatomía Patológica Y Educación Física y Deportiva, Facultad de Medicina, Universidad de Málaga, 29071 Málaga, Spain.ORCID 0000-0002-6436-1361
Antonia SerranoInstituto de Investigación Biomédica de Málaga-IBIMA, 29071 Málaga, Spain.
Hospital Regional Universitario de Málaga · ESInstituto de Investigación Biomédica de Málaga · ESUniversidad de Málaga · ESHospital Universitario 12 De Octubre · ESInstituto de Salud Carlos III · ESUniversidad Complutense de Madrid · ES

Funding

Plan Propio de Investigación y Transferencia de la Universidad de Málaga Ayudas para proyectos puente B4Proyectos de Investigación en Drogodependencias funded by Delegación del Gobierno para el Plan Nacional sobre Drogas, PND2017/043, PND2018/033, PNSD2018/044 and PND2019/040Proyectos de Investigación en Salud funded by Consejería de Salud y Familias, Junta de Andalucía PI-194-2014 and PI-0140-2018Proyectos de Investigación en Salud funded by ISCIII and ERDF/ESF PI17/02026, PI19/00886 and PI19/01577Proyectos I+D+I en el marco del Programa Operativo FEDER Andalucía 2014-2020 funded by Consejería de Economía, Conocimiento, Empresas y Universidad, Junta de Andalucía UMA18-FEDERJA-004 and UMA18-FEDERJA-059Redes Temáticas, Ministerio de Economía y Competitividad RD16/0017/0001
6 · The paper itself

Abstract

Lysophosphatidic acid (LPA) is an endogenous lysophospholipid and a bioactive lipid that is synthesized by the enzyme autotaxin (ATX). The ATX-LPA axis has been associated with cognitive dysfunction and inflammatory diseases, mainly in a range of nonalcoholic liver diseases. Recently, preclinical and clinical evidence has suggested a role of LPA signaling in alcohol use disorder (AUD) and AUD-related cognitive function. However, the ATX-LPA axis has not been sufficiently investigated in alcoholic liver diseases. An exploratory study was conducted in 136 participants, 66 abstinent patients with AUD seeking treatment for alcohol (alcohol group), and 70 healthy control subjects (control group). The alcohol group was divided according to the presence of comorbid liver diseases (i.e., fatty liver/steatosis, alcoholic steatohepatitis, or cirrhosis). All participants were clinically evaluated, and plasma concentrations of total LPA and ATX were measured using enzyme-linked immunosorbent assays. Data were primarily analyzed using analysis of covariance (ANCOVA) while controlling for age, body mass index, and sex. Logistic regression models were created to assess the association of the ATX-LPA axis and AUD or liver disease. LPA and ATX were log

Indexed as

alcohol use disorderautotaxincomorbidityliver diseaselysophosphatidic acid

Identifiers

PMID34572393
PMCPMC8469650
OpenAlexW3200965612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.